---

2015

ルーム内検索
全41件   1  2  3 次の20件>>
ID
トピック名
閲覧/投稿
最新投稿
作成
278 【基礎研究】Understanding the role of hyperdiploidy in myeloma prognosis: which trisomies really matter? 143 / 0
2016-10-14
KMF CRC
277 【基礎研究】Immunoglobulin G4-positive plasma cell myeloma. 148 / 0
2016-10-14
KMF CRC
276 【基礎研究】Prospective analysis of antigen-specific immunity, stem-cell antigens, and immune checkpoints in monoclonal gammopathy. 160 / 0
2016-10-14
KMF CRC
275 【基礎研究】Pleomorphic plasma cell leukemia. 148 / 0
2016-10-14
KMF CRC
274 【基礎研究】The novel mechanism of lenalidomide activity. 159 / 0
2016-10-14
KMF CRC
273 【臨床研究】Carfilzomib, pomalidomide, and dexamethasone for relapsed or refractory myeloma. 185 / 0
2016-10-14
KMF CRC
272 【臨床研究】Dividing plasma cells in the cerebrospinal fluid of a patient with refractory multiple myeloma. 148 / 0
2016-10-14
KMF CRC
271 【基礎研究】Atypical plasma cell leukemia mistaken for lymphocytosis on blood count. 159 / 0
2016-10-14
KMF CRC
270 【基礎研究】Expanding the peptidome for immunotherapy. 156 / 0
2016-10-14
KMF CRC
269 【基礎研究】Myeloma escape from immunity: an inside" job." 153 / 0
2016-10-14
KMF CRC
268 【基礎研究】Circulating reactive plasma cells in the setting of peripheral T-cell lymphoma mimicking plasma cell leukemia. 168 / 0
2016-10-14
KMF CRC
244 【基礎研究】Prediction of high- and low-risk multiple myeloma based on gene expression and the International Staging System. 301 / 0
2015-10-15
KMF CRC
243 【臨床研究】Melphalan, prednisone, and thalidomide vs melphalan, prednisone, and lenalidomide (ECOG E1A06) in untreated multiple myeloma. 295 / 0
2015-10-15
KMF CRC
242 【基礎研究】The antigenic landscape of multiple myeloma: mass spectrometry (re)defines targets for T-cell-based immunotherapy. 259 / 0
2015-10-15
KMF CRC
241 【レビュー】How I treat fragile myeloma patients. 317 / 0
2015-10-15
KMF CRC
240 【基礎研究】The forkhead transcription factor FOXP1 represses human plasma cell differentiation. 267 / 0
2015-10-15
KMF CRC
239 【レビュー】How I treat high risk myeloma. 255 / 0
2015-10-15
KMF CRC
238 【臨床研究】Critical analysis of the stringent complete response in multiple myeloma: contribution of sFLC and bone marrow clonality. 270 / 0
2015-10-15
KMF CRC
237 【基礎研究】Dendritic cells accumulate in the bone marrow of myeloma patients where they protect tumor plasma cells from CD8+ T cell killing. 236 / 0
2015-10-15
KMF CRC
236 【基礎研究】Evidence of an epigenetic origin for high-risk 1q21 copy number aberrations in multiple myeloma. 243 / 0
2015-10-15
KMF CRC
全41件   1  2  3 次の20件>>